Transplantation of CRISPR-Cas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients With Severe Sickle Cell Disease

Disease Name: 
Sickle Cell Disease
Study Status: 
Date: 
May 19, 2023